ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nivolumab Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27N7625
Home | Market Reports | Health| Health Conditions| Cancer
Global Nivolumab Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nivolumab Injection Market Research Report 2025

Code: QYRE-Auto-27N7625
Report
July 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Allergan plc
Ono Pharmaceutical
Sinopharm
Bristol–Myers Squibb

Nivolumab Injection Market

The global market for Nivolumab Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.
North American market for Nivolumab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nivolumab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm, Bristol-Myers Squibb, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nivolumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nivolumab Injection.
The Nivolumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nivolumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nivolumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nivolumab Injection Market Report

Report Metric Details
Report Name Nivolumab Injection Market
Segment by Type
  • 100IU
  • 50IU
  • Other
Segment by Application
  • Unresectable Melanoma
  • Metastatic Melanoma
  • Metastatic Squamous NSCLC
  • Classical Hodgkin Lymphoma
  • Renal Cell Carcinoma
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Allergan, Ono Pharmaceutical, Sinopharm, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nivolumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nivolumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nivolumab Injection Market report?

Ans: The main players in the Nivolumab Injection Market are AbbVie, Allergan, Ono Pharmaceutical, Sinopharm, Bristol-Myers Squibb

What are the Application segmentation covered in the Nivolumab Injection Market report?

Ans: The Applications covered in the Nivolumab Injection Market report are Unresectable Melanoma, Metastatic Melanoma, Metastatic Squamous NSCLC, Classical Hodgkin Lymphoma, Renal Cell Carcinoma, Other

What are the Type segmentation covered in the Nivolumab Injection Market report?

Ans: The Types covered in the Nivolumab Injection Market report are 100IU, 50IU, Other

1 Nivolumab Injection Market Overview
1.1 Product Definition
1.2 Nivolumab Injection by Type
1.2.1 Global Nivolumab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Nivolumab Injection by Application
1.3.1 Global Nivolumab Injection Market Value by Application (2024 VS 2031)
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global Nivolumab Injection Market Size Estimates and Forecasts
1.4.1 Global Nivolumab Injection Revenue 2020-2031
1.4.2 Global Nivolumab Injection Sales 2020-2031
1.4.3 Global Nivolumab Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nivolumab Injection Market Competition by Manufacturers
2.1 Global Nivolumab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nivolumab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nivolumab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nivolumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nivolumab Injection, Product Type & Application
2.7 Global Key Manufacturers of Nivolumab Injection, Date of Enter into This Industry
2.8 Global Nivolumab Injection Market Competitive Situation and Trends
2.8.1 Global Nivolumab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nivolumab Injection Players Market Share by Revenue
2.8.3 Global Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nivolumab Injection Market Scenario by Region
3.1 Global Nivolumab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nivolumab Injection Sales by Region: 2020-2031
3.2.1 Global Nivolumab Injection Sales by Region: 2020-2025
3.2.2 Global Nivolumab Injection Sales by Region: 2026-2031
3.3 Global Nivolumab Injection Revenue by Region: 2020-2031
3.3.1 Global Nivolumab Injection Revenue by Region: 2020-2025
3.3.2 Global Nivolumab Injection Revenue by Region: 2026-2031
3.4 North America Nivolumab Injection Market Facts & Figures by Country
3.4.1 North America Nivolumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nivolumab Injection Sales by Country (2020-2031)
3.4.3 North America Nivolumab Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nivolumab Injection Market Facts & Figures by Country
3.5.1 Europe Nivolumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nivolumab Injection Sales by Country (2020-2031)
3.5.3 Europe Nivolumab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nivolumab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Nivolumab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nivolumab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Nivolumab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nivolumab Injection Market Facts & Figures by Country
3.7.1 Latin America Nivolumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nivolumab Injection Sales by Country (2020-2031)
3.7.3 Latin America Nivolumab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nivolumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Nivolumab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nivolumab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nivolumab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nivolumab Injection Sales by Type (2020-2031)
4.1.1 Global Nivolumab Injection Sales by Type (2020-2025)
4.1.2 Global Nivolumab Injection Sales by Type (2026-2031)
4.1.3 Global Nivolumab Injection Sales Market Share by Type (2020-2031)
4.2 Global Nivolumab Injection Revenue by Type (2020-2031)
4.2.1 Global Nivolumab Injection Revenue by Type (2020-2025)
4.2.2 Global Nivolumab Injection Revenue by Type (2026-2031)
4.2.3 Global Nivolumab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Nivolumab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nivolumab Injection Sales by Application (2020-2031)
5.1.1 Global Nivolumab Injection Sales by Application (2020-2025)
5.1.2 Global Nivolumab Injection Sales by Application (2026-2031)
5.1.3 Global Nivolumab Injection Sales Market Share by Application (2020-2031)
5.2 Global Nivolumab Injection Revenue by Application (2020-2031)
5.2.1 Global Nivolumab Injection Revenue by Application (2020-2025)
5.2.2 Global Nivolumab Injection Revenue by Application (2026-2031)
5.2.3 Global Nivolumab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Nivolumab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Nivolumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Nivolumab Injection Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Company Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Nivolumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Nivolumab Injection Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Ono Pharmaceutical
6.3.1 Ono Pharmaceutical Company Information
6.3.2 Ono Pharmaceutical Description and Business Overview
6.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ono Pharmaceutical Nivolumab Injection Product Portfolio
6.3.5 Ono Pharmaceutical Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Company Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Nivolumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sinopharm Nivolumab Injection Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Company Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bristol-Myers Squibb Nivolumab Injection Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nivolumab Injection Industry Chain Analysis
7.2 Nivolumab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nivolumab Injection Production Mode & Process Analysis
7.4 Nivolumab Injection Sales and Marketing
7.4.1 Nivolumab Injection Sales Channels
7.4.2 Nivolumab Injection Distributors
7.5 Nivolumab Injection Customer Analysis
8 Nivolumab Injection Market Dynamics
8.1 Nivolumab Injection Industry Trends
8.2 Nivolumab Injection Market Drivers
8.3 Nivolumab Injection Market Challenges
8.4 Nivolumab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Allergan plc
Ono Pharmaceutical
Sinopharm
Bristol–Myers Squibb
List of Tables
 Table 1. Global Nivolumab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nivolumab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nivolumab Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nivolumab Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nivolumab Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nivolumab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nivolumab Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nivolumab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nivolumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nivolumab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Nivolumab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nivolumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nivolumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nivolumab Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nivolumab Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Nivolumab Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nivolumab Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Nivolumab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nivolumab Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Nivolumab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nivolumab Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Nivolumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nivolumab Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nivolumab Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nivolumab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nivolumab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nivolumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nivolumab Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nivolumab Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nivolumab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nivolumab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nivolumab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nivolumab Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nivolumab Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nivolumab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nivolumab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nivolumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nivolumab Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nivolumab Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nivolumab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nivolumab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nivolumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nivolumab Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nivolumab Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nivolumab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nivolumab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nivolumab Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Nivolumab Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Nivolumab Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Nivolumab Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Nivolumab Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nivolumab Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nivolumab Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Nivolumab Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Nivolumab Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nivolumab Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nivolumab Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Nivolumab Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Nivolumab Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Nivolumab Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Nivolumab Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nivolumab Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nivolumab Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Nivolumab Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Nivolumab Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nivolumab Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Nivolumab Injection Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Allergan Company Information
 Table 76. Allergan Description and Business Overview
 Table 77. Allergan Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Allergan Nivolumab Injection Product
 Table 79. Allergan Recent Developments/Updates
 Table 80. Ono Pharmaceutical Company Information
 Table 81. Ono Pharmaceutical Description and Business Overview
 Table 82. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ono Pharmaceutical Nivolumab Injection Product
 Table 84. Ono Pharmaceutical Recent Developments/Updates
 Table 85. Sinopharm Company Information
 Table 86. Sinopharm Description and Business Overview
 Table 87. Sinopharm Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sinopharm Nivolumab Injection Product
 Table 89. Sinopharm Recent Developments/Updates
 Table 90. Bristol-Myers Squibb Company Information
 Table 91. Bristol-Myers Squibb Description and Business Overview
 Table 92. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bristol-Myers Squibb Nivolumab Injection Product
 Table 94. Bristol-Myers Squibb Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Nivolumab Injection Distributors List
 Table 98. Nivolumab Injection Customers List
 Table 99. Nivolumab Injection Market Trends
 Table 100. Nivolumab Injection Market Drivers
 Table 101. Nivolumab Injection Market Challenges
 Table 102. Nivolumab Injection Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nivolumab Injection
 Figure 2. Global Nivolumab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nivolumab Injection Market Share by Type: 2024 & 2031
 Figure 4. 100IU Product Picture
 Figure 5. 50IU Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Nivolumab Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nivolumab Injection Market Share by Application: 2024 & 2031
 Figure 9. Unresectable Melanoma
 Figure 10. Metastatic Melanoma
 Figure 11. Metastatic Squamous NSCLC
 Figure 12. Classical Hodgkin Lymphoma
 Figure 13. Renal Cell Carcinoma
 Figure 14. Other
 Figure 15. Global Nivolumab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Nivolumab Injection Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Nivolumab Injection Sales (2020-2031) & (K Units)
 Figure 18. Global Nivolumab Injection Average Price (US$/Unit) & (2020-2031)
 Figure 19. Nivolumab Injection Report Years Considered
 Figure 20. Nivolumab Injection Sales Share by Manufacturers in 2024
 Figure 21. Global Nivolumab Injection Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Nivolumab Injection Players: Market Share by Revenue in Nivolumab Injection in 2024
 Figure 23. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Nivolumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Nivolumab Injection Sales Market Share by Country (2020-2031)
 Figure 26. North America Nivolumab Injection Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Nivolumab Injection Sales Market Share by Country (2020-2031)
 Figure 30. Europe Nivolumab Injection Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Nivolumab Injection Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Nivolumab Injection Revenue Market Share by Region (2020-2031)
 Figure 38. China Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Nivolumab Injection Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Nivolumab Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Nivolumab Injection Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Nivolumab Injection Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Nivolumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Nivolumab Injection by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Nivolumab Injection by Type (2020-2031)
 Figure 60. Global Nivolumab Injection Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Nivolumab Injection by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Nivolumab Injection by Application (2020-2031)
 Figure 63. Global Nivolumab Injection Price (US$/Unit) by Application (2020-2031)
 Figure 64. Nivolumab Injection Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Nivolumab Market Research Report 2024
Nivolumab Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Penpulimab Injection Market Research Report 2024
OPDIVO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Avastin Bevacizumab Biosimilars Market Research Report 2024
Global ALK Inhibitors Market Research Report 2024
Global Targeted Drug ALK Inhibitors for NSCLC Market Research Report 2024
Global Nimotuzumab Market Research Report 2024
Global Dacomitinib API Market Research Report 2024
Global Neoantigen Targeted Therapies Market Insights Forecast to 2030
Global Savolitinib Tablets Market Research Report 2024
Global Monoclonal Antibodies for Non small Cell Lung Cancer Market Research Report 2025
Global ALK Positive Lung Cancer Treatment Market Insights Forecast to 2030
Global Neoantigen Targeted Therapy Market Research Report 2024
Global Injectable Targeted Therapy Market Research Report 2024
Global Metastatic Lung Adenocarcinoma Treatment Market Research Report 2024
Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Injection Drug Market Research Report 2025
Global Anti tumor Injection Market Research Report 2024
Global Non small Cell Lung Cancer Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions